Detalles de la búsqueda
1.
Eribulin for patients with metastatic extramammary Paget disease: Study protocol for a single-arm phase II trial.
Exp Dermatol
; 33(1): e14993, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38284191
2.
Protocol for treating lumbar spinal canal stenosis with a combination of ultrapurified, allogenic bone marrow-derived mesenchymal stem cells and in situ-forming gel: a multicentre, prospective, double-blind randomised controlled trial.
BMJ Open
; 13(2): e065476, 2023 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36731929
3.
Status of the Current Treatment Options and Potential Future Targets in Uterine Leiomyosarcoma: A Review.
Cancers (Basel)
; 14(5)2022 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267488
4.
Exploratory clinical trial on the safety and capability of dMD-001 in lumbar disc herniation: Study protocol for a first-in-human pilot study.
Contemp Clin Trials Commun
; 23: 100805, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34278043
5.
Efficacy of bezafibrate for preventing myopathic attacks in patients with very long-chain acyl-CoA dehydrogenase deficiency.
Brain Dev
; 43(2): 214-219, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32798077
6.
Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial.
BMJ Open
; 9(7): e026403, 2019 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31289066
7.
Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan; 2nd report QOL survey.
Mol Genet Metab Rep
; 20: 100496, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31372341
8.
Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model.
Cancer Sci
; 99(3): 623-30, 2008 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-18201272
9.
Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn's disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose-response trial.
BMJ Open Gastroenterol
; 5(1): e000206, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29915666
10.
Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan.
Mol Genet Metab Rep
; 15: 55-63, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29552494
11.
A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
Mol Cancer Ther
; 5(11): 2634-43, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17121910
12.
Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas.
J Med Chem
; 48(5): 1359-66, 2005 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-15743179
13.
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth.
Mol Cancer Ther
; 3(12): 1639-49, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15634658
14.
Biologic and clinical activity of tivozanib (AV-951, KRN-951), a selective inhibitor of VEGF receptor-1, -2, and -3 tyrosine kinases, in a 4-week-on, 2-week-off schedule in patients with advanced solid tumors.
Clin Cancer Res
; 17(22): 7156-63, 2011 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21976547
15.
Synthesis and structure-activity relationship for new series of 4-phenoxyquinoline derivatives as specific inhibitors of platelet-derived growth factor receptor tyrosine kinase.
Bioorg Med Chem
; 11(23): 5117-33, 2003 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-14604675
Resultados
1 -
15
de 15
1
Próxima >
>>